Cesar Chavez Public Charter School, DC's Series 2010 Revenue Bonds Rated 'BBB-' Nov 10

  • ID: 1771459
  • November 2010
  • Standard & Poors
1 of 3

CHICAGO (Standard & Poor's) Nov. 4, 2010--Standard & Poor's Ratings Services assigned its 'BBB-' rating, with a stable outlook, to the District of Columbia' s series 2010 tax-exempt fixed-rate revenue bonds, issued for Cesar Chavez Public Charter School. "The rating is based on our assessment of the school's positive relationship with its authorizer, District of Columbia Public Charter School Board (DCPCSB); and test scores that are comparable with those of other charter schools after implementing recent initiatives to improve test scores," said Standard & Poor's credit analyst Corey Friedman. These strengths are constrained by our view of the school's risk of nonrenewal of the charter, which must be renewed multiple times before final bond maturity; and need for aggressive marketing...

Companies mentioned in this report are:
- Cesar Chavez Pub Charter Sch
- District of Columbia

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Cesar Chavez Pub Charter Sch
- District of Columbia

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.